Top Links


  • Annex Publishers

    Annex Publishers, as an Open Access publication model allows the dissemination of research articles to the worldwide community. We offer you the advantage of interaction with the most effective minds from the scientific community. All articles printed under open access will be accessed by anyone.
  • Why Open Access?

    Provides for unrestricted access to journals and publications, along with an ideal platform for thousands of scholarly brains to return together for development of science. Open Access helps accelerate the pace of scientific discovery, encourage innovation, enrich education, and stimulate the economy to enhance the knowledge of the general public.
Submit Manuscript


Recent Articles

Acute Type C Botulism with Fatal Consequences in a Holstein Breeding Establishment in Northern Italy

BOTULISM is a neuro-paralytic intoxication illness caused by the ingestion of neurotoxins of Clostridium botulinum with contaminated water or food [1]. The Gram-positive spore-producing bacterium Cl. botulinum is found worldwide and can survive in spore form for up to 30 years in numerous substrates in the environment [2-4]. Cl. botulinum is classified into 7 or 8 different types (A, B, C (C1, C2), D, E, F, G) depending on the antigen properties of the botulinum neurotoxins (BoNT) produced, with intoxication mostly appearing in cattle following the ingestion of neurotoxins of type C and D and, less frequently, of type B [5-9].

Topical Delivery System for Phytochemicals: Capsaicin and Capsicum Tincture

Capsaicin, an active ingredient of Capsicum fruit, is currently undergoing “revival” in the clinical management of pain. However, the choice of its formulation is rather limited to the use of “old-fashioned” tinctures and recently the patches. In an attempt to improve the therapeutic outcome and develop its skin-friendly formulation, we prepared the vesicle-based drug delivery system with capsaicin.

Pharmacy Compounding Quality Control and Pharmaceutical Development Strategies for Seventeen alpha Hydroxyprogesterone Caproate in Prevention of Preterm Delivery

Seventeen alpha hydroxyprogesterone caproate (17-OHPC) is the only FDA-approved drug labeled for prevention of preterm delivery. This drug is also available as a compounded product from licensed compounding pharmacies. This article reviews the FDA approval history and pharmacy compounding quality control data of 17-OHPC, as well as briefly discusses possible future pharmaceutical development strategies for 17-OHPC.